| Literature DB >> 23421741 |
Hemmin A Hassan1, Runnak A Majid, Nawshirwan G Rashid, Bryar E Nuradeen, Qalandar H Abdulkarim, Tahir A Hawramy, Rekawt M Rashid, Alton B Farris, Jeannette Guarner, Michael D Hughson.
Abstract
BACKGROUND: Deep eosinophilic granulomatous abscesses, as distinguished from eosinophilic subcutaneous abscesses, are rare. Most reports are from the Far-East and India where the most commonly attributed cause is Toxocara. Sulaimaniyah in Northeastern Iraq has experienced an outbreak of eosinophilic granulomatous liver and gastrointestinal (GI) abscesses beginning in 2009. The purpose of this study was to determine the etiology and guide treatment.Entities:
Mesh:
Year: 2013 PMID: 23421741 PMCID: PMC3583806 DOI: 10.1186/1471-2334-13-91
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Clinical, radiologic, and laboratory characteristics of 14 patients diagnosed with granulomatous and eosinophilic gastrointestinal and hepatic abscesses in Sulaimaniyah, Iraq, 2009–2012
| 1. | 48 | M | 5/2010; histology | Cashier/healthy | Yes | Yes | 12% | Abdominal pain/2 mos, intestinal mass, obstruction | CT: Cecal, ascending colon mass, stricture. Rt. lobe liver mass | Neg |
| 2. | 1.5 | M | 8/2010; histology, biopsy of pelvic mass | Previously well infant | Yes | Yes | 29% | Abdominal pain, pelvic mass/1 wk. | CT: Necrotic mass, lower abdomen and pelvis | Neg |
| 3. | 59 | M | 10/2010; histology | Merchant, dry goods/healthy | Yes | Yes (6 kg) | No | Abdominal pain and mass. Itching/3 mos. | CT: Cecal mass | Neg |
| 4. | 53 | M | 2/2012; histology | Soldier/healthy | Yes | Yes | Not tested | Abdominal pain/1 mo., intestinal mass, obstruction | CT: Cecal, transverse colon masses, strictures | Neg |
| 5. | 39 | M | 5/2012; histology | Military office worker/chronic gastritis | Yes | Yes | 9% | Persistent cough, sore throat/1 mo. | CT: Diffuse soft tissue mass of oropharynx. Transverse colon mass, stricture | Neg |
| 6. | 1.5 | M | 8/2012; histology | Previously well infant | Yes | Yes | 21% | Abdominal pain/2-3 d, intestinal mass, obstruction | CT: Cecal mass, thick ascending colon with stricture | Neg |
| 7. | 30 | M | 6/2009; histology, serology | Janitor/healthy | Yes | Yes | 26% | R subcostal pain/1 mo. | CT: Cystic mass Rt. lobe liver. Mild splenomegaly | Pos |
| 8. | 30 | F | 5/2010; histology, serology | Housewife/healthy | No | No | > 50% | R subcostal pain/1 wk. | US: Small hypodense liver lesions. Mild splenomegaly | Pos |
| 9. | 56 | F | 6/2010; histology, serology | Housewife/healthy | No | Yes (7 kg) | 35% | R subcostal pain/1-2 wks. | US: Small hypodense liver lesions | Pos |
| 10. | 56 | F | 8/2010; histology, serology | Housewife/healthy | Yes | Yes | 26% | R subcostal pain/1-2 wks. | US: Cystic mass Rt. lobe liver | Pos |
| 11. | 33 | M | 11/2011; histology, serology | Shopkeeper/healthy | Yes | Yes (10 kg) | 72% | R subcostal pain/2-3 wks. | CT: Cystic mass Rt. lobe liver. Mild splenomegaly | Pos |
| 12. | 22 | F | 5/2010; histology, serology | Student/healthy | No | Yes (4 kg) | 74% | R subcostal pain/1 wk. | US: Small hypodense liver lesions. Mild splenomegaly | Borderline |
| 13. | 17 | F | 5/2009; histology | Student/healthy | Yes | Yes | 23% | Abdominal pain/2-3 wks. | US: Cystic mass Rt. lobe liver. Mild splenomegaly | Neg |
| 14. | 32 | M | 4/2009; histology | Soldier/healthy | No | No | 29% | R subcostal pain/1-2 mos. | CT: Cystic mass Rt. lobe liver | Neg |
Abbreviations: M male, F female. Mo, month; wk, week; d, day. CT, computerized tomography; US, ultrasonography. Neg, negative; Pos, positive.
Pathological findings, treatment, and follow-up for 14 patients diagnosed with granulomatous and eosinophilic gastrointestinal and hepatic abscesses in Sulaimaniyah, Iraq, 2009–2012
| 1. | Right hemicolectomy Segmental hepatectomy | Cecal, ascending colon, and localized liver masses | 8-12 cm | Pauci-septate hyphae | Oral itraconozol, 6 mos. | Recurrent obstruction after 5 mos. | Asymptomatic,24 mos. |
| 2. | Biopsy of mass | Pelvic mass, intestinal site uncertain | 9 cm | Pauci-septate hyphae | IV amphotercin B, 2 d. | Died | |
| 3. | Right hemicolectomy | Cecal mass | 6 cm | Pauci-septate hyphae | Oral itraconozol, 6 mos | None | Asymptomatic, 26 mos. |
| 4. | Right hemi and transverse colectomy | Cecal and transverse colon masses | 17 cm | Pauci-septate hyphae | Oral itraconozol, 6 mos. | Recurrent obstruction after 3 mos. | Asymptomatic, 10 mos. |
| 5. | Transverse colectomy | Oropharyngeal and transverse colon masses | 20x9 cm | Pauci-septate hyphae | Itraconozol: IV14 d, Oral 7 mos | None | Asymptomatic, 7 mos. |
| 6. | Right hemicolectomy | Cecal mass | 4 cm | Pauci-septate hyphae | Oral itraconozol, 4 mos. | None | Asymptomatic, 4 mos. |
| 7. | Segmental hepatectomy | Liver mass, localized | 4x6 cm | No | Albendazole 400mg/d, 3 d | None | Asymptomatic, 41 mos. |
| 8. | Cholecystectomy, wedge liver biopsy | Liver, diffuse abscesses | 0.5-2 cm | No | Albendazole 400 mg/d, 3 d | None | Asymptomatic, 30 mos. |
| 9. | Cholecytectomy, wedge liver biopsy | Liver, diffuse abscesses | 0.5-2 cm | No | Albendazole 400 mg/d, 3 d | Common duct fluke after 2 yrs | Asymptomatic, 30 mos. |
| 10. | Segmental hepatectomy | Liver mass, localized | 3 cm | No | Albendazole 400 mg/d, 3 d | None | Asymptomatic, 28 mos. |
| 11. | Segmental hepatectomy | Liver mass, localized | 5 cm | No | Albendazole 400 mg/d, 3 d | None | Asymptomatic, 13 mos. |
| 12. | Cholecytectomy, wedge liver biopsy | Liver, diffuse abscesses | 0.5-2 cm | No | Albendazole 400 mg/d, 3 d | None | Asymptomatic, 30 mos. |
| 13. | Segmental hepatectomy | Liver mass, localized | 4x5 cm | No | Albendazole 400 mg/d, 3 d | None | Asymptomatic, 42 mos. |
| 14. | Segmental hepatectomy | Liver mass, localized | 2 cm | No | Albendazole 400 mg/d, 3 d | None | Asymptomatic, |
Abbreviations: Mo, month d, day.
Figure 1Patient 1. A right hemicolectomy specimen showing a cecal mass with irregular mucosal ulceration.
Figure 2Patient 1. The wall of the cecum demonstrates a stellate abscess with a necrotic center containing eosinophils surrounded by granulomatous inflammation with Langerhans giant cells. Fungal elements can be seen surrounded by an eosinophilic Splendore-Hoeppli reaction. Hematoxylin and eosin stain ×100.
Figure 3Patient 5. The microscopy of a tonsilar biopsy reveals an intense eosinophilic inflammatory reaction containing fungal hyphae surrounded by the Splendore-Hoeppli phenomenon. Hematoxylin and eosin stain ×200.
Figure 4Patient 1. The fungi consist of broad pauci septate hyphae consistent with basidiobolomycosis. Periodic acid-Schiff hematoxylin stain ×400.
Figure 5Patient 5. Magnetic resonance imaging showing a mass at the base of the tongue that markedly narrows and shifts the oropharynx laterally.
Figure 6Patient 7. Localized abscess of the right lobe of the liver in a patient serologically positive for F. hepatica.
Figure 7Patient 7. The abscess consists of a peripheral rim of epithelioid histiocytes and central necrosis with neutrophils and eosinophils. Numerous eosinophil crystals are present. Hematoxylin and eosin ×400.
Figure 8Liver of a bull slaughtered at the regional abattoir showing an adult fluke of that was found in the thickened bile duct below the parasite.
Pathological and clinical laboratory findings in the differential diagnosis of abdominal eosinophilic granulomatous abscesses
| Pathologic findings | | | | |
| Anatomic site involved | | | | |
| Intestine/colon mass | 80% of patients | Rare, ectopic | Not reported | [ |
| Liver abscesses | Localized, 30% of patients | Diffuse more common than localized. | Diffuse with VLM, localized uncommon | [ |
| Microscopic findings | | | | |
| Granulomatous inflammation | Present | Present | Present | [ |
| Eosinophils | Present | Present | Present | [ |
| Charcot-Leyden crystals | Not prominent | Numerous | Present | [ |
| Organisms in tissues | Pauci-septate hyphae with Splendore-Hoeppli reaction required for diagnosis | Very rare, if present ova more common than flukes | Larvae 30% of cases | [ |
| Clinical laboratory findings | | | | |
| Eosinophilia | 76% of patients, usually not very high | Consistently positive in acute stage | Consistently positive with VLM | [ |
| Serology | | | | |
| Before treatment | Immunodiffusion positive 50% of patients, not routinely available. | ELISA 87-93% sensitivity, 98% specificity for acute stage | ELISA 78% sensitivity, 98% specificity for VLM | [ |
| After treatment | Unknown | > 90% negative at 1 year. | Positive for years after VLM | [ |